ExitValue.ai

BUYER DISCOVERY

Who buys pharmacies?

104 disclosed pharmacyacquisitions analyzed — the active strategic and private equity buyers, how often each one buys, and their most recent named deals. Sourced from SEC filings and verified M&A press releases.

Quick answers

How many disclosed transactions?
104 disclosed pharmacy acquisitions with a named acquirer.
Most active buyers
Diplomat Pharmacy, Inc. (6) · BioScrip, Inc. (5) · Omnicell, Inc. (4) · CVS Health Corporation (4) · UnitedHealth Group Inc. (3) · Catamaran Corp. (3)
What would these buyers pay for my business?
Run the ExitValue.ai calculator to price your pharmacy against these 104 disclosed transactions. The engine surfaces what each buyer pool pays for your size, margin, and growth profile.

Top strategic buyers

Operators, larger competitors, and corporate consolidators acquiring pharmacy businesses for synergy and capability fill.

AcquirerDealsMedian deal sizeRecent targets
Diplomat Pharmacy, Inc.6$72MAffinity Biotech, Inc. (2017), Focus Rx Pharmacy Services Inc. (2017), TNH Advanced Specialty Pharmacy (2016), BioRx (2015)
BioScrip, Inc.5$93MHS Infusion Holdings, Inc. (2016), CarePoint Partners Holdings (2013), HomeChoice Partners (2013), InfuScience, Inc. (2012)
Omnicell, Inc.4$191MMarkeTouch Media (2022), Pharmaceutical Strategies Group 340B Link (2020), Aesynt Incorporated (2016), MTS Medication Technologies, Inc. (2012)
CVS Health Corporation4$1.1BPremier's Specialty Pharmacy Business (2019), EntrustRx Specialty Pharmacy (2018), Omnicare, Inc. (2015), Coram (2013)
UnitedHealth Group Inc.3$898MDiplomat Pharmacy Inc. (2019), Avella Specialty Pharmacy (2018), Genoa Healthcare (2018)
Catamaran Corp.3$385MRestat / Healthcare Solutions (2015), Salveo Specialty Pharmacy (2014), Restat (2013)
Better Choice Company, Inc.2$77MChoice Specialty Pharmacy Group (2025), SRx Health (2024)
Medicure Inc.2$4MWest Olympia Pharmacy Inc. (2025), Marley Drug, Inc (2020)
McKesson Corp.2$692MRx Savings Solutions (2022), Biologics, Inc. (2016)
CareRx Corporation2$6MRexall LTC Pharmacy Business (2021), SmartMeds Pharmacy Inc. (2021)
Rite Aid Corp.2$1.1BBartell Drug Company (2020), Envision Rx Holdings (2015)
Centric Health Corporation2$39MRemedy'sRx Specialty Pharmacy (2020), Pharmacare Fulfillment Center Ltd. (2015)

Top private equity buyers

Private equity firms and PE-backed platforms rolling up pharmacy businesses. Platform-tier buyers typically pay up for scale, clean financials, and a management layer that survives integration.

AcquirerDealsMedian deal sizeRecent targets
Frazier Healthcare Partners2$475MBioMatrix (2024), Comprehensive Pharmacy Services (2019)
Court Square Capital and WindRose Health1$1.1BSoleo Health (2025)
Vistria Group / General Atlantic / Nautic Partners1$1.4BPANTHERx (2022)
Ridgemont Equity Partners1$170MAmerican Outcomes Management (2021)
Waud Capital Partners1$400MPromptCare (2021)
Silver Lake1$2.8BGoodRx (2018)
KKR Co., LP1$1.4BPharMerica Corp. (2017)
Madison Dearborn Partners1$1.1BWalgreens Infusion Services (2015)
Harvest Partners1$234MAxelaCare Health Solutions (2013)
TPG Capital1$885MEnvision Rx Holdings (2013)

Recent M&A activity

Disclosed pharmacy acquisitions by year.

2010
5
2012
7
2013
13
2014
3
2015
15
2016
7
2017
6
2018
4
2019
8
2020
9
2021
7
2022
7
2024
6
2025
6
2026
1

Methodology note

Acquirer activity reflects disclosed M&A transactions in the ExitValue.ai database, filtered to pharmacy businesses with a named acquirer. Counts include deals with disclosed financials only — total transaction volume in this segment is typically 2–3x larger. The valuation engine reveals what each buyer pool pays for your specific business when you run the calculator. Full methodology

What's your pharmacy worth to these acquirers?

12-input M&A-grade workup with sellability score, named comparable deals, and AI-written commentary. 2 minutes.

  • Sellability score with 5-driver breakdown and lift estimates
  • Named comparable M&A transactions in your sub-vertical
  • AI-written analysis grounded in your specific inputs
Run my valuation analysis →

Engine-grounded estimate. Comparable named deals on the full results page.

More on pharmacy valuations

Based on 104 disclosed M&A transactions · methodology